These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19646743)

  • 1. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.
    Chakravarthy MV; Lodhi IJ; Yin L; Malapaka RR; Xu HE; Turk J; Semenkovich CF
    Cell; 2009 Aug; 138(3):476-88. PubMed ID: 19646743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ligand for an orphan receptor.
    Wolf G
    Nutr Rev; 2010 May; 68(5):316-8. PubMed ID: 20500791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
    Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
    Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
    Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
    Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARα.
    Jensen-Urstad AP; Song H; Lodhi IJ; Funai K; Yin L; Coleman T; Semenkovich CF
    J Lipid Res; 2013 Jul; 54(7):1848-59. PubMed ID: 23585690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylcholine and PPARalpha: a relevant connection in liver disease?
    Lamaziere A; Wolf C
    Gastroenterol Clin Biol; 2010; 34(4-5):250-1. PubMed ID: 20392582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver.
    Guo D; Sarkar J; Suino-Powell K; Xu Y; Matsumoto K; Jia Y; Yu S; Khare S; Haldar K; Rao MS; Foreman JE; Monga SP; Peters JM; Xu HE; Reddy JK
    J Biol Chem; 2007 Dec; 282(50):36766-76. PubMed ID: 17962186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor alpha is required for feedback regulation of highly unsaturated fatty acid synthesis.
    Li Y; Nara TY; Nakamura MT
    J Lipid Res; 2005 Nov; 46(11):2432-40. PubMed ID: 16106047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dibutyl phthalate on lipid metabolism in liver and hepatocytes based on PPARα/SREBP-1c/FAS/GPAT/AMPK signal pathway.
    Zhang W; Li JY; Wei XC; Wang Q; Yang JY; Hou H; Du ZW; Wu XA
    Food Chem Toxicol; 2021 Mar; 149():112029. PubMed ID: 33508418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME; Garcimartin A; Muñoz-Martínez E
    Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
    Kersten S; Stienstra R
    Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
    Kim MS; Sweeney TR; Shigenaga JK; Chui LG; Moser A; Grunfeld C; Feingold KR
    Metabolism; 2007 Feb; 56(2):267-79. PubMed ID: 17224343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
    Chakravarthy MV; Pan Z; Zhu Y; Tordjman K; Schneider JG; Coleman T; Turk J; Semenkovich CF
    Cell Metab; 2005 May; 1(5):309-22. PubMed ID: 16054078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dual PPARα/γ agonists and their effects on lipid metabolism.
    Gao Q; Hanh J; Váradi L; Cairns R; Sjöström H; Liao VW; Wood P; Balaban S; Ong JA; Lin HY; Lai F; Hoy AJ; Grewal T; Groundwater PW; Hibbs DE
    Bioorg Med Chem; 2015 Dec; 23(24):7676-84. PubMed ID: 26616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
    Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
    Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl-CoA Thioesterase 1 (ACOT1) Regulates PPARα to Couple Fatty Acid Flux With Oxidative Capacity During Fasting.
    Franklin MP; Sathyanarayan A; Mashek DG
    Diabetes; 2017 Aug; 66(8):2112-2123. PubMed ID: 28607105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.